The Senate early Friday morning narrowly confirmed Rep. Tom Price to serve as the next secretary of Health and Human Services.

The vote of 52 to 47 to confirm the Georgia Republican, a former orthopedic surgeon, will have an impact on the growing debate over legislation that would repeal and replace Obamacare. As HHS secretary, Price will be responsible for overseeing the administration of the healthcare law’s exchanges and regulations.

He also will be responsible for overseeing the Food and Drug Administration, Centers for Disease Control and Prevention, the National Institutes of Health and other related agencies.

Price’s nomination became a flashpoint in the debate over Obamacare, as Democrats took umbrage with Price’s replacement plan he authored while in the House. Democrats also criticized Price’s prior positions on Medicare and Medicaid, saying that he has previously supported turning Medicare into a voucher program and Medicaid into a block grant program.

“The war on seniors by the Trump administration begins when we confirm Rep. Price,” said Senate Minority Leader Chuck Schumer, of New York, on the Senate floor Thursday.

Others were concerned about what Price’s nomination will mean for Obamacare coverage.

“We have a secretary who is not someone interested in having a basic set of services identified in healthcare, like maternity care,” said Sen. Debbie Stabenow, D-Mich., on the Senate floor Thursday night.

Republicans countered that as a doctor, Price is the best candidate to serve as HHS secretary and take on the problems created by Obamacare.

“At a time when our healthcare system is in distress, I believe that Dr. Price will put his vast experience to good use and be decisive in not only finding solutions, but implementing them as well,” said Sen. Orrin Hatch, R-Utah, on the Senate floor.

Opposition to wussiness is the driving force in U.S. politics

Also from the Washington Examiner

The abhorrence of wussiness has become the driving force in U.S. politics.

02/10/17 12:56 AM

“Our healthcare system has undergone serious turmoil as of late and this was undoubtedly caused at least in part by the rolling calamity known as Obamacare,” said Sen. Tom Cotton, R-Ark., referring to Obamacare’s thin competition and climbing premiums.

Hatch also chided Democrats for their attempt to block Price’s confirmation and other nominees.

“The confirmation of any of President Trump’s Cabinet nominees, it seems, will bring about untold destruction, the likes of which America has never seen,” Hatch said sarcastically.

Hatch is chairman of the Senate Finance Committee, which confirmed Price without any Democratic votes after Democrats boycotted the vote.

At first, the committee hearing to vote on Price was delayed because at least one Democratic member was needed to reach a quorum to proceed. After the initial boycott, Hatch suspended the rules and brought the nomination to a vote without any Democrats present.

Court's rejection of immigration ban raises stakes for Gorsuch

Also from the Washington Examiner

Senators will further scrutinize the nominee’s ability to act independently from the president.

02/10/17 12:26 AM

Democrats did the same boycott for other nominees, such as Scott Pruitt as administrator of the Environmental Protection Agency.

Democrats weren’t upset only about Price’s views on Obamacare. Several have called for an investigation by the Senate and the Securities and Exchange Commission on Price’s stock deals.

Price bought more than $50,000 in discounted stock in the Australian biotech company Innate Immunotherapeutics, Democrats also criticized Price for buying more than $2,000 stock in a company called Zimmer Biomet less than a week before introducing legislation that could have benefited the medical device maker.

Price said in his confirmation hearings that he was unaware he was getting a discounted deal on the Australian stock. Regarding Zimmer, Price said a broker made the purchase and he was unaware of it.

Sen. Al Franken, D-Minn., said the stock trades should be enough to sink the nomination.

“Congressman Price’s conflicted financial investments and his affiliation with conspiracy-peddling extremists should be enough to disqualify his nomination,” Franken said on the Senate floor.

Hatch blasted Democrats’ attacks on Price’s stock trades, saying that the allegations have no merit.

“I’ve participated in quite a few confirmation debates during my time in the Senate,” Hatch said. “One thing I’ve learned is that, if the opponents of a particular nomination keep moving their focus from one set of allegations to another, more often than not, they don’t have a leg to stand on. That is very much the case with regard to the attacks that have been hurled at Dr. Price.”

Trump faults 'political decision' of appeals court, promises future win

Top Story

The president promised additional legal action from his Justice Department.

02/09/17 8:00 PM

Source link

About the Author:

Leave a Reply